Steroidogenic Factor 1 Protects Mice from Obesity-Induced Glucose Intolerance Via Improving Glucose-Stimulated Insulin Secretion by Beta Cells.

Yan Guo,Liehua Liu,Yanglei Cheng,Hai Li,Xuesi Wan,Jiajing Ma,Juan Liu,Weiwei Liang,Pengyuan Zhang,Jie Chen,Xiaopei Cao,Hongyu Guan,Haipeng Xiao,Yanbing Li

DOI: https://doi.org/10.1016/j.isci.2023.106451

IF: 5.8

2023-01-01

iScience

Abstract:As a potential druggable nuclear receptor, steroidogenic factor 1 (SF1) regu-lates obesity and insulin resistance in the ventromedial hypothalamic nucleus. Herein, we sought to demonstrate its expression and functions in islets in the development of obesity-induced diabetes. SF1 was barely detected in the beta cells of lean mice but highly expressed in those of non-diabetic obese mice, while decreased in diabetic ones. Conditional deletion of SF1 in beta cells predisposed diet-induced obese (DIO) mice to glucose intolerance by perturb-ing glucose-stimulated insulin secretion (GSIS). Consistently, forced expression of SF1 restored favorable glucose homeostasis in DIO and db/db mice by improving GSIS. In isolated islets and MIN6, overexpression of SF1 also poten-tiated GSIS, mediated by improvement of mitochondrial ATP production. The underlying mechanisms may involve oxidative phosphorylation and lipid meta-bolism. Collectively, SF1 in beta cell preserves GSIS to promote beta-cell adap-tation to obesity and hence is a potential therapeutic target for obesity-induced diabetes.